BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7669735)

  • 1. Accumulation of genetic changes during development and progression of hepatocellular carcinoma: loss of heterozygosity of chromosome arm 1p occurs at an early stage of hepatocarcinogenesis.
    Kuroki T; Fujiwara Y; Tsuchiya E; Nakamori S; Imaoka S; Kanematsu T; Nakamura Y
    Genes Chromosomes Cancer; 1995 Jul; 13(3):163-7. PubMed ID: 7669735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors.
    Okabe H; Ikai I; Matsuo K; Satoh S; Momoi H; Kamikawa T; Katsura N; Nishitai R; Takeyama O; Fukumoto M; Yamaoka Y
    Hepatology; 2000 May; 31(5):1073-9. PubMed ID: 10796882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelotype analysis of hepatocellular carcinoma.
    Piao Z; Park C; Park JH; Kim H
    Int J Cancer; 1998 Jan; 75(1):29-33. PubMed ID: 9426686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic changes and histopathological grades in human hepatocellular carcinomas.
    Konishi M; Kikuchi-Yanoshita R; Tanaka K; Sato C; Tsuruta K; Maeda Y; Koike M; Tanaka S; Nakamura Y; Hattori N
    Jpn J Cancer Res; 1993 Aug; 84(8):893-9. PubMed ID: 8407553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma.
    Nishida N; Fukuda Y; Kokuryu H; Sadamoto T; Isowa G; Honda K; Yamaoka Y; Ikenaga M; Imura H; Ishizaki K
    Int J Cancer; 1992 Jul; 51(6):862-8. PubMed ID: 1322376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of cumulative allelic losses with tumor aggressiveness in hepatocellular carcinoma.
    Tamura S; Nakamori S; Kuroki T; Sasaki Y; Furukawa H; Ishikawa O; Imaoka S; Nakamura Y
    J Hepatol; 1997 Oct; 27(4):669-76. PubMed ID: 9365043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic loss at chromosome band 8p21.3-p22 is associated with progression of hepatocellular carcinoma.
    Emi M; Fujiwara Y; Ohata H; Tsuda H; Hirohashi S; Koike M; Miyaki M; Monden M; Nakamura Y
    Genes Chromosomes Cancer; 1993 Jul; 7(3):152-7. PubMed ID: 7687868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal instability and human hepatocarcinogenesis.
    Nishida N; Nishimura T; Ito T; Komeda T; Fukuda Y; Nakao K
    Histol Histopathol; 2003 Jul; 18(3):897-909. PubMed ID: 12792902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis.
    Midorikawa Y; Yamamoto S; Tsuji S; Kamimura N; Ishikawa S; Igarashi H; Makuuchi M; Kokudo N; Sugimura H; Aburatani H
    Hepatology; 2009 Feb; 49(2):513-22. PubMed ID: 19105209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive allelotyping of human hepatocellular carcinoma.
    Nagai H; Pineau P; Tiollais P; Buendia MA; Dejean A
    Oncogene; 1997 Jun; 14(24):2927-33. PubMed ID: 9205099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive allelotyping of well-differentiated human hepatocellular carcinoma with semiquantitative determination of chromosomal gain or loss.
    Nishimura T; Nishida N; Itoh T; Kuno M; Minata M; Komeda T; Fukuda Y; Ikai I; Yamaoka Y; Nakao K
    Genes Chromosomes Cancer; 2002 Dec; 35(4):329-39. PubMed ID: 12378527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance of loss of heterozygosity on chromosome 13q in hepatocellular carcinoma.
    Wong CM; Lee JM; Lau TC; Fan ST; Ng IO
    Clin Cancer Res; 2002 Jul; 8(7):2266-72. PubMed ID: 12114430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological significance of loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in China.
    Zhang SH; Cong WM; Xian ZH; Wu MC
    World J Gastroenterol; 2005 May; 11(20):3034-9. PubMed ID: 15918185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
    Pang JZ; Qin LX; Ren N; Hei ZY; Ye QH; Jia WD; Sun BS; Lin GL; Liu DY; Liu YK; Tang ZY
    Clin Cancer Res; 2007 Dec; 13(24):7363-9. PubMed ID: 18094418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13q.
    Kuroki T; Fujiwara Y; Nakamori S; Imaoka S; Kanematsu T; Nakamura Y
    Br J Cancer; 1995 Aug; 72(2):383-5. PubMed ID: 7640222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic classification of combined hepatocellular-cholangiocarcinoma.
    Fujii H; Zhu XG; Matsumoto T; Inagaki M; Tokusashi Y; Miyokawa N; Fukusato T; Uekusa T; Takagaki T; Kadowaki N; Shirai T
    Hum Pathol; 2000 Sep; 31(9):1011-7. PubMed ID: 11014564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of alterations in p73 gene, related to p53 at 1p36, in human hepatocellular carcinoma.
    Aoki T; Miyamoto A; Marubashi S; Nagano H; Umeshita K; Fujiwara Y; Dono K; Nakamori S; Sakon M; Monden M
    Int J Oncol; 2004 Feb; 24(2):441-6. PubMed ID: 14719122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-density allelotyping of chromosome 8p in hepatocellular carcinoma and clinicopathologic correlation.
    Chan KL; Lee JM; Guan XY; Fan ST; Ng IO
    Cancer; 2002 Jun; 94(12):3179-85. PubMed ID: 12115350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype.
    Boige V; Laurent-Puig P; Fouchet P; Fléjou JF; Monges G; Bedossa P; Bioulac-Sage P; Capron F; Schmitz A; Olschwang S; Thomas G
    Cancer Res; 1997 May; 57(10):1986-90. PubMed ID: 9157995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A preliminary study of loss of heterozygosity on chromosome 1p in primary hepatocellular carcinoma].
    Shao J; Li H; Liew CT; Wu Q; Liang X; Hou J
    Zhonghua Bing Li Xue Za Zhi; 1999 Feb; 28(1):28-30. PubMed ID: 11869508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.